Open AccessLiver computed tomographic perfusion for monitoring the early therapeutic response to sorafenib in advanced hepatocellular carcinoma patients
Author(s) -
Xiaojun Shen,
Dong Wu,
Min Tang,
Hui–Chuan Sun,
Yuan Ji,
Cheng Huang,
Mengsu Zeng
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_979_17
Subject(s) - sorafenib , hepatocellular carcinoma , medicine , response evaluation criteria in solid tumors , progressive disease , perfusion , perfusion scanning , nuclear medicine , radiology , therapeutic effect , gastroenterology , oncology , disease
Sorafenib is the only approved treatment for advanced hepatocellular carcinoma (HCC). However, it is a diagnostic challenge to monitor its early treatment effects on HCC.